Yongping Song

8.7k total citations · 3 hit papers
231 papers, 4.8k citations indexed

About

Yongping Song is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Yongping Song has authored 231 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Hematology, 82 papers in Oncology and 62 papers in Molecular Biology. Recurrent topics in Yongping Song's work include CAR-T cell therapy research (45 papers), Acute Myeloid Leukemia Research (39 papers) and Lymphoma Diagnosis and Treatment (36 papers). Yongping Song is often cited by papers focused on CAR-T cell therapy research (45 papers), Acute Myeloid Leukemia Research (39 papers) and Lymphoma Diagnosis and Treatment (36 papers). Yongping Song collaborates with scholars based in China, United States and United Kingdom. Yongping Song's co-authors include Delong Liu, Jifeng Yu, Juanjuan Zhao, Zhongxing Jiang, Wenzhi Tian, Quande Lin, Haowei Sun, Kongming Wu, Ming Yi and Xiaodong Lyu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Yongping Song

214 papers receiving 4.8k citations

Hit Papers

Targeting CD47 for cancer immunotherapy 2021 2026 2022 2024 2021 2021 2024 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Targeting CD47 for cancer immunotherapy
    2021 240 citations Zhongxing Jiang, Jifeng Yu et al. profile →
  2. The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update
    2021 150 citations Mingzhe Han, Qifa Liu et al. profile →
  3. Targeting TIGIT for cancer immunotherapy: recent advances and future directions
    2024 54 citations Zhongxing Jiang, Yongping Song et al. profile →

Peers

Yongping Song
Xi Zhang China
David B. Miklos United States
Taira Maekawa Japan
Aaron P. Rapoport United States
Carmine Selleri Italy
Kiyohiko Hatake Japan
Josè Antonio Pérez-Simón Spain
Beverly Torok‐Storb United States
Junya Kuroda Japan
Torsten Tonn Germany
Xi Zhang China
Yongping Song
Citations per year, relative to Yongping Song Yongping Song (= 1×) peers Xi Zhang

Countries citing papers authored by Yongping Song

Since Specialization
Citations

This map shows the geographic impact of Yongping Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongping Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongping Song more than expected).

Fields of papers citing papers by Yongping Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongping Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongping Song. The network helps show where Yongping Song may publish in the future.

Co-authorship network of co-authors of Yongping Song

This figure shows the co-authorship network connecting the top 25 collaborators of Yongping Song. A scholar is included among the top collaborators of Yongping Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongping Song. Yongping Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Jianliang, Yongping Song, Keshu Zhou, et al.. (2024). Preliminary results from a phase I study of IMM0306 in patients with relapsed or refractory CD20-positive B-cell non-Hodgkin's lymphoma.. Journal of Clinical Oncology. 42(16_suppl). 7060–7060. 2 indexed citations
2.
Zhang, Wenli, Mengmeng Liu, Wei Li, & Yongping Song. (2024). Immune cells in the B-cell lymphoma microenvironment: From basic research to clinical applications. Chinese Medical Journal. 137(7). 776–790. 5 indexed citations
3.
Li, Xingchen, Wenzhi Tian, Zhongxing Jiang, et al.. (2024). Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions. Cancer Immunology Immunotherapy. 73(2). 31–31. 33 indexed citations
4.
Liban, Tyler, Bin Zhang, Yongping Song, et al.. (2024). A novel anti-LAG-3/TIGIT bispecific antibody exhibits potent anti-tumor efficacy in mouse models as monotherapy or in combination with PD-1 antibody. Scientific Reports. 14(1). 10661–10661. 12 indexed citations
5.
Li, Wei, Weijie Cao, Wenli Zhang, et al.. (2023). Identification of potential resistance mechanisms and therapeutic targets for the relapse of BCMA CAR-T therapy in relapsed/refractory multiple myeloma through single-cell sequencing. Experimental Hematology and Oncology. 12(1). 44–44. 37 indexed citations
6.
7.
Guo, Rongqun, Jingjing Kong, Ping Tang, et al.. (2023). Unbiased Single‐Cell Sequencing of Hematopoietic and Immune Cells from Aplastic Anemia Reveals the Contributors of Hematopoiesis Failure and Dysfunctional Immune Regulation. Advanced Science. 11(10). e2304539–e2304539. 14 indexed citations
8.
Li, Zhen, Fengkuan Yu, Yanli Zhang, et al.. (2023). Selection of hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma. Frontiers in Oncology. 13. 1193237–1193237. 4 indexed citations
9.
Chen, Naifei, Chengfei Pu, Lingling Zhao, et al.. (2023). A phase 1 dose escalation study of GCC19CART: A novel coupled CAR therapy for patients with metastatic colorectal cancer.. Journal of Clinical Oncology. 41(16_suppl). 3547–3547. 1 indexed citations
10.
Lyu, Xiaodong, Dandan Zhu, Yan Chen, et al.. (2022). Whole-genome sequencing as an alternative to analyze copy number abnormalities in acute myeloid leukemia and myelodysplastic syndrome. Leukemia & lymphoma. 63(10). 2301–2310.
11.
Liu, Mengmeng, Lina Liu, Yongping Song, Wei Li, & Linping Xu. (2022). Targeting macrophages: a novel treatment strategy in solid tumors. Journal of Translational Medicine. 20(1). 586–586. 48 indexed citations
12.
Han, Lu, Jishuai Zhang, Jian Zhou, et al.. (2021). Single VHH-directed BCMA CAR-T cells cause remission of relapsed/refractory multiple myeloma. Leukemia. 35(10). 3002–3006. 33 indexed citations
13.
14.
15.
Zhou, Keshu, Qing Zhang, Huifang Zhao, et al.. (2017). Loss of thyroid hormone receptor interactor 13 inhibits cell proliferation and survival in human chronic lymphocytic leukemia. Oncotarget. 8(15). 25469–25481. 18 indexed citations
16.
Lyu, Xiaodong, Xianwei Wang, Lina Zhang, et al.. (2017). Detection of 22 common leukemic fusion genes using a single-step multiplex qRT-PCR-based assay. Diagnostic Pathology. 12(1). 55–55. 10 indexed citations
17.
Deng, Mei, et al.. (2016). Clinical features of mucosa-associated lymphoid tissue lymphoma patients with monoclonal gammopathy. 25(4). 208–210. 1 indexed citations
18.
Fan, Ruihua, et al.. (2013). [Effect of TAK1 gene silencing on the apoptosis of Kasumi-1 cells induced by arsenic trioxide].. PubMed. 34(5). 417–20. 1 indexed citations
19.
Fang, Baijun, Ling Mai, Ning Li, & Yongping Song. (2011). Favorable Response of Chronic Refractory Immune Thrombocytopenic Purpura to Mesenchymal Stem Cells. Stem Cells and Development. 21(3). 497–502. 23 indexed citations
20.
Liu, Kai‐Yan, Yu Wang, Mingzhe Han, et al.. (2010). Valganciclovir for pre-emptive therapy of cytomegalovirus viraemia after hematopoietic stem cell transplantation: a prospective multi-center trial.. PubMed. 123(16). 2199–205. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xi Zhang Breakdown of academic impact, for papers by David B. Miklos Breakdown of academic impact, for papers by Taira Maekawa Breakdown of academic impact, for papers by Aaron P. Rapoport Breakdown of academic impact, for papers by Carmine Selleri Breakdown of academic impact, for papers by Kiyohiko Hatake Breakdown of academic impact, for papers by Josè Antonio Pérez-Simón Breakdown of academic impact, for papers by Beverly Torok‐Storb Breakdown of academic impact, for papers by Junya Kuroda Breakdown of academic impact, for papers by Torsten Tonn
Rankless by CCL
2026